Search details
1.
Novel Gain-of-Function Mutation in Stat1 Sumoylation Site Leads to CMC/CID Phenotype Responsive to Ruxolitinib.
J Clin Immunol
; 39(8): 776-785, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31512162
2.
Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC).
Eur J Immunol
; 45(10): 2834-46, 2015 Oct.
Article
in English
| MEDLINE | ID: mdl-26255980
3.
Prevalence and predictors of out-of-range cuff pressure of endotracheal and tracheostomy tubes: a prospective cohort study in mechanically ventilated patients.
BMC Anesthesiol
; 15: 147, 2015 Oct 15.
Article
in English
| MEDLINE | ID: mdl-26471790
4.
Double Trouble? CMC with a Mutation in both AIRE and STAT1.
J Clin Immunol
; 38(6): 635-637, 2018 08.
Article
in English
| MEDLINE | ID: mdl-30054782
5.
Impact of a national collaborative project to improve the care of mechanically ventilated patients.
PLoS One
; 18(1): e0280744, 2023.
Article
in English
| MEDLINE | ID: mdl-36716310
6.
Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation.
J Allergy Clin Immunol
; 135(2): 551-3, 2015 Feb.
Article
in English
| MEDLINE | ID: mdl-25662309
7.
Oesophageal candidiasis and squamous cell cancer in patients with gain-of-function STAT1 gene mutation.
United European Gastroenterol J
; 5(5): 625-631, 2017 Aug.
Article
in English
| MEDLINE | ID: mdl-28815025
Results
1 -
7
de 7
1
Next >
>>